Conning Inc. Has $2.76 Million Position in Monsanto Company (MON)
Conning Inc. cut its stake in shares of Monsanto Company (NYSE:MON) by 0.4% during the second quarter, according to its most recent 13F filing with the SEC. The firm owned 23,288 shares of the basic materials company’s stock after selling 90 shares during the period. Conning Inc.’s holdings in Monsanto were worth $2,756,000 as of its most recent SEC filing.
Other hedge funds have also recently modified their holdings of the company. Acrospire Investment Management LLC purchased a new stake in shares of Monsanto during the first quarter valued at $113,000. Pinnacle Financial Partners Inc. bought a new position in shares of Monsanto during the second quarter valued at approximately $114,000. JNBA Financial Advisors raised its position in shares of Monsanto by 3.9% in the first quarter. JNBA Financial Advisors now owns 1,193 shares of the basic materials company’s stock valued at $135,000 after buying an additional 45 shares in the last quarter. Armbruster Capital Management Inc. raised its position in shares of Monsanto by 12.2% in the second quarter. Armbruster Capital Management Inc. now owns 1,147 shares of the basic materials company’s stock valued at $136,000 after buying an additional 125 shares in the last quarter. Finally, Penserra Capital Management LLC raised its position in shares of Monsanto by 9.5% in the first quarter. Penserra Capital Management LLC now owns 1,288 shares of the basic materials company’s stock valued at $145,000 after buying an additional 112 shares in the last quarter. 74.79% of the stock is currently owned by hedge funds and other institutional investors.
Shares of Monsanto Company (MON) opened at 116.59 on Wednesday. The company’s 50 day moving average price is $117.23 and its 200 day moving average price is $115.65. The firm has a market capitalization of $51.22 billion, a P/E ratio of 25.18 and a beta of 1.07. Monsanto Company has a one year low of $97.35 and a one year high of $118.97.
Monsanto (NYSE:MON) last posted its earnings results on Wednesday, June 28th. The basic materials company reported $1.93 EPS for the quarter, topping the Thomson Reuters’ consensus estimate of $1.74 by $0.19. The business had revenue of $4.23 billion during the quarter, compared to the consensus estimate of $4.18 billion. Monsanto had a return on equity of 45.26% and a net margin of 14.11%. Monsanto’s revenue was up 1.0% on a year-over-year basis. During the same quarter last year, the company earned $2.17 EPS. On average, analysts expect that Monsanto Company will post $4.89 EPS for the current fiscal year.
The business also recently announced a quarterly dividend, which will be paid on Friday, October 27th. Investors of record on Friday, October 6th will be given a dividend of $0.54 per share. The ex-dividend date of this dividend is Thursday, October 5th. This represents a $2.16 annualized dividend and a dividend yield of 1.85%. Monsanto’s dividend payout ratio (DPR) is presently 46.75%.
MON has been the topic of several recent analyst reports. Zacks Investment Research upgraded shares of Monsanto from a “hold” rating to a “buy” rating and set a $132.00 price target on the stock in a research note on Friday, June 16th. Vetr upgraded shares of Monsanto from a “hold” rating to a “buy” rating and set a $122.35 price target on the stock in a research note on Wednesday, July 12th. UBS AG lowered shares of Monsanto from a “buy” rating to a “neutral” rating and set a $128.00 price target on the stock. in a research note on Friday, August 18th. BidaskClub upgraded shares of Monsanto from a “sell” rating to a “hold” rating in a research note on Saturday, August 19th. Finally, Royal Bank Of Canada reiterated a “sector perform” rating and issued a $128.00 price target (up from $120.00) on shares of Monsanto in a research note on Thursday, June 29th. One investment analyst has rated the stock with a sell rating, eleven have assigned a hold rating and nine have assigned a buy rating to the stock. The company has a consensus rating of “Hold” and a consensus price target of $123.43.
In related news, SVP Janet M. Holloway sold 3,337 shares of the firm’s stock in a transaction that occurred on Friday, June 2nd. The stock was sold at an average price of $118.00, for a total transaction of $393,766.00. Following the completion of the transaction, the senior vice president now owns 44,405 shares in the company, valued at approximately $5,239,790. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this link. Also, EVP Steven Mizell sold 11,300 shares of the firm’s stock in a transaction that occurred on Monday, July 3rd. The stock was sold at an average price of $118.57, for a total value of $1,339,841.00. Following the transaction, the executive vice president now owns 55,011 shares of the company’s stock, valued at approximately $6,522,654.27. The disclosure for this sale can be found here. Insiders have sold a total of 74,470 shares of company stock valued at $8,791,281 in the last 90 days. 0.79% of the stock is owned by corporate insiders.
Monsanto Company Profile
Monsanto Company (Monsanto), along with its subsidiaries, is a provider of agricultural products for farmers. The Company provides seeds, biotechnology trait products, herbicides and digital agriculture tools to farmers. The Company operates through two segments: Seeds and Genomics, and Agricultural Productivity.
Want to see what other hedge funds are holding MON? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Monsanto Company (NYSE:MON).
Receive News & Ratings for Monsanto Company Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Monsanto Company and related companies with Analyst Ratings Network's FREE daily email newsletter.